CDP vs REGN · P/E 24, rev $753.3M vs P/E 14, rev $14.34B
COPT Defense Properties (CDP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
COPT Defense Properties (CDP) is a reit - office company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CDP revenue for 2024-12-31 was $753.3M. Net income was $143.9M. Revenue was up 10.0% from 2023-12-31 to 2024-12-31. CDP currently screens at market cap $3.84B and trailing P/E 24.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CDP currently screens at market cap $3.84B and trailing P/E 24.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CDP and REGN stock pages for the full models.
Not investment advice.